First-in-Human Evaluation of the Zenith LAAO System for Stroke Prevention in High-Risk Atrial Fibrillation Patients (AuriGen)

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Medtronic; Recor</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Medtronic; Recor</li></ul>